On December 28, 2023 TiumBio Co., Ltd. closed the transaction. The company issued 2,320,185 convertible preferred shares at an issue price of KRW 8,620 per share for gross proceeds of KRW 19,999,994,700.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,280 KRW | +0.55% | +12.17% | -25.49% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
57,800 KRW | +0.52% | +4.14% | 761M | ||
7,280 KRW | +0.55% | +12.17% | 136M | ||
1st Jan change | Capi. | |
---|---|---|
-25.49% | 136M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- A321550 Stock
- News TiumBio Co., Ltd.
- TiumBio Co., Ltd. announced that it has received KRW 19.9999947 billion in funding from SK Chemicals Co.,Ltd